Earnings History Data for Aerie Pharmaceuticals, Inc. (AERI) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Aerie Pharmaceuticals, Inc.

Aerie Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It is focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. The Company's lead `Dual- Action` product and `Triple-Action` products are under developmental stages. Aerie Pharmaceuticals, Inc. is headquartered in Bedminster, New Jersey.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
04-08-2022	AH	4:00 PM ET (Aug 4)	AERI	Aerie Pharmaceuticals, Inc.	375.37	-0.32	-0.52	-0.67	Aerie Pharmaceuticals Non-GAAP EPS of -$0.32 beats by $0.23, revenue of $33.3M beats by $0.71M [8/4/2022 4:02 PM]	8.91	1.54 (20.90%)	8.91	0.0 (0.00%)	4.81 - 17.21	1,508,780	410,000	600
Aerie Pharmaceuticals Non-GAAP EPS of -$0.32 beats by $0.23, revenue of $33.3M beats by $0.71M [8/4/2022 4:02 PM] Aerie Pharma rises 14% after Q2 result beat on higher glaucoma franchise sales [8/5/2022 11:29 AM] Aerie Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update [Aug-04-22 04:01PM] Aerie Pharmaceuticals (AERI) Reports Q2 Loss, Tops Revenue Estimates [Aug-04-22 05:45PM] Aerie (AERI) Q2 Loss Narrower Than Expected, Sales Beat [Aug-05-22 12:20PM]
05-05-2022	AH	4:00 PM ET (May 5)	AERI	Aerie Pharmaceuticals, Inc.	364.77	-0.66	-0.66	-0.72	Aerie Pharmaceuticals Non-GAAP EPS of -$0.66 misses by $0.01, revenue of $29.83M misses by $0.07M [5/5/2022 4:12 PM]	6.26	-1.46 (-18.91%)	7.72	0.0 (0.00%)	5.46 - 19.26	633,329	430,000	1,383
Aerie Pharmaceuticals Non-GAAP EPS of -$0.66 misses by $0.01, revenue of $29.83M misses by $0.07M [5/5/2022 4:12 PM] Aerie Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update [May-05-22 04:01PM] Aerie Pharmaceuticals (AERI) Reports Q1 Loss, Misses Revenue Estimates [May-05-22 05:55PM] Aerie (AERI) Q1 Loss Wider Than Expected, Revenues Rise Y/Y [May-06-22 03:48PM]
24-02-2022	AH	4:00 PM ET (Feb 24)	AERI	Aerie Pharmaceuticals, Inc.	275.62	1.09	-0.68	-0.79	Aerie Pharmaceuticals Non-GAAP EPS of $1.09 beats by $1.77, revenue of $114.7M beats by $83.54M [2/24/2022 4:10 PM]	7.62	1.72 (29.15%)	6.39	0.49 (8.31%)	5.46 - 21.30	2,673,840	880,000	1,087
Aerie Pharmaceuticals appoints Gary Sternberg as medical chief [2/24/2022 6:53 AM] Aerie Pharmaceuticals Non-GAAP EPS of $1.09 beats by $1.77, revenue of $114.7M beats by $83.54M [2/24/2022 4:10 PM] Aerie swings to profits in Q4 thanks to licensing deal with Santen [2/25/2022 10:46 AM] Drug/Biotech Stocks' Q4 Earnings on Feb 24: MRNA, EBS & More [Feb-23-22 11:44AM] Aerie Pharmaceuticals Appoints Gary Sternberg, M.D., M.B.A. as Chief Medical Officer [Feb-24-22 06:30AM] Aerie Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update [Feb-24-22 04:01PM] Aerie Pharmaceuticals (AERI) Tops Q4 Earnings and Revenue Estimates [Feb-24-22 06:00PM] Aerie (AERI) Q4 Earnings Beat Estimates, Revenues Up Y/Y [Feb-25-22 10:14AM]
04-11-2021	AH	4:00 PM ET (Nov 4)	AERI	Aerie Pharmaceuticals, Inc.	520.51	-0.72	-0.62	-0.65	Aerie Pharmaceuticals EPS misses by $0.10, beats on revenue [11/4/2021 4:39 PM]	12.24	0.23 (1.92%)	11.81	-0.20 (-1.67%)	9.55 - 21.30	911,874	720,000	1,416
Aerie Pharmaceuticals EPS misses by $0.10, beats on revenue [11/4/2021 4:39 PM] Aerie Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update [Nov-04-21 04:01PM] Aerie Pharmaceuticals (AERI) Reports Q3 Loss, Tops Revenue Estimates [Nov-04-21 05:15PM] Strong week for Aerie Pharmaceuticals (NASDAQ:AERI) shareholders doesn't alleviate pain of three-year loss [Nov-05-21 06:33AM] Aerie's (AERI) Q3 Earnings Miss Estimates, Revenues Rise Y/Y [Nov-05-21 10:37AM] Aerie Pharmaceuticals, inc (AERI) Q3 2021 Earnings Call Transcript [Nov-05-21 01:31PM]
04-08-2021	AH	4:00 PM ET (Aug 4)	AERI	Aerie Pharmaceuticals, Inc.	739.98	-0.67	-0.65	-0.83	Aerie Pharmaceuticals EPS misses by $0.18, beats on revenue [8/4/2021 4:04 PM]	14.99	-0.01 (-0.07%)	15.00	0.0 (0.00%)	9.01 - 21.30	272,381	400,000	7,735
Aerie Pharmaceuticals EPS misses by $0.18, beats on revenue [8/4/2021 4:04 PM] Aerie Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update [Aug-04-21 04:01PM] Aerie Pharmaceuticals (AERI) Reports Q2 Loss, Tops Revenue Estimates [Aug-04-21 05:15PM] Aerie Pharmaceuticals, inc (AERI) Q2 2021 Earnings Call Transcript [Aug-04-21 11:31PM] Aerie's(AERI) Q2 Loss Wider Than Expected, Revenues Beat [Aug-05-21 11:42AM]
05-05-2021	AH	4:00 PM ET (May 5)	AERI	Aerie Pharmaceuticals, Inc.	803.69	-0.72	-0.69	-0.84	Aerie Pharmaceuticals EPS misses by $0.04, misses on revenue [5/5/2021 4:07 PM]	17.10	0.26 (1.57%)	16.84	0.0 (0.00%)	9.01 - 21.30	1,004,818	410,000	11,008
Is a Surprise Coming for Aerie (AERI) This Earnings Season? [May-04-21 09:17AM] CollPlant (CLGN) to Report Q1 Earnings: What's in the Cards? [May-04-21 08:46AM] Aerie Pharmaceuticals, Inc. to Host Earnings Call [May-05-21 03:15PM] Aerie Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update [May-05-21 04:01PM] Aerie Pharmaceuticals (AERI) Reports Q1 Loss, Misses Revenue Estimates [May-05-21 06:05PM] Aerie Pharmaceuticals to Participate in the Bank of America Securities 2021 Healthcare Conference [May-06-21 07:30AM] Aerie's (AERI) Q1 Loss Wider Than Expected, Revenues Miss [May-06-21 01:24PM]
25-02-2021	AH	4:00 PM ET (Feb 25)	AERI	Aerie Pharmaceuticals, Inc.	746.70	-0.79	-0.75	-0.96	Aerie Pharmaceuticals EPS misses by $0.06, beats on revenue [2/25/2021 4:20 PM]	18.35	2.54 (16.07%)	15.81	0.0 (0.00%)	9.01 - 19.42	1,434,062	518,940	3,706
Aerie Pharmaceuticals EPS misses by $0.06, beats on revenue [2/25/2021 4:20 PM] Aerie Pharmaceuticals shares rise after Q4 topline beat [2/26/2021 10:40 AM] Aerie Pharmaceuticals (AERI) Reports Q4 Loss, Tops Revenue Estimates [Feb-25-21 05:45PM]
05-11-2020	AH	4:00 PM ET (Nov 5)	AERI	Aerie Pharmaceuticals, Inc.	506.54	-0.65	-0.81	-0.86	Aerie Pharmaceuticals EPS beats by $0.15, beats on revenue [11/5/2020 4:30 PM]	10.57	-0.16 (-1.49%)	11.00	0.27 (2.52%)	9.01 - 26.26	1,866,702	888,727	119

06-08-2020	AH	4:00 PM ET (Aug 6)	AERI	Aerie Pharmaceuticals, Inc.	551.58	-0.83	-0.79	-0.80	Aerie Pharmaceuticals EPS misses by $0.03, beats on revenue [8/6/2020 4:15 PM]	12.49	0.39 (3.22%)	12.50	0.40 (3.31%)	10.80 - 26.26	1,672,287	765,901	8,023

06-05-2020	AH		AERI	Aerie Pharmaceuticals, Inc.	716.54	-0.84	-0.75	-0.78		0.0	0.0 (0.00%)	0.0	0.0 (0.00%)	0.0 - 0.0	0	0	0